Family Medicine Doctors in Midland, NC Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Mary C. Russell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12925 Highway 601, Ste 300, Midland, NC 28107 Phone: 704-888-3702 |
 Theodore M. Kelley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12925 Highway 601, Ste 300, Midland, NC 28107 Phone: 704-888-3702 |
Ms. Edith Elaine Cloud, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12925 Highway 601, Midland Family Medicine, Midland, NC 28107 Phone: 704-888-3702 Fax: 704-888-4192 |
Gregory A. Russell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12925 Highway 601, Ste 300, Midland, NC 28107 Phone: 704-888-3702 |
News Archive
Mayo Clinic offers patient education resources to small medical practices
Mayo Clinic today announced that its thousands of patient education resources will be offered to small medical practices throughout the United States. This will be accomplished through an agreement with drchrono, an electronic health record company formed in 2009. Future contracts may make the materials even more broadly available.
Researchers address logistical and ethical quandaries of cross-cultural research
A group of social scientists who conduct cross-cultural research are casting a critical lens on their own practices.
Study examines cognitive effects of head impacts among student athletes
Dartmouth faculty and students played prominent roles in a recent study on the cognitive effects of head impacts among student athletes. Tested at the beginning and end of one season, 22 percent of those students who participated in contact sports scored significantly lower in memory and learning skills than expected, as opposed to only 4 percent of non-contact sport athletes.
Cephalon, Mesoblast to develop, commercialize novel adult MPC therapeutics
Cephalon, Inc. and Mesoblast Limited, today announced they have entered into a strategic alliance to develop and commercialize novel adult Mesenchymal Precursor Stem Cell therapeutics for degenerative conditions of the cardiovascular and central nervous systems.
Numerate collaborates with Intellikine to identify drug-like inhibitors of PI3 kinase alpha
Numerate, Inc. and Intellikine, Inc. today announced the successful conclusion of their research collaboration to discover novel small molecule compounds targeting the PI3K/mTOR signaling pathway. The collaboration combined Intellikine's unique capabilities in x-ray crystal structure-guided medicinal chemistry and drug discovery with Numerate's powerful computational drug design platform to identify potent, selective and drug-like inhibitors of PI3 kinase alpha, an important target in cancer therapy.
› Verified 9 days ago